第1章 グローバル脱灰骨基質（DBM）市場 エグゼクティブサマリー
1.1. グローバル脱灰骨基質（DBM）市場規模および予測（2022年～2032年）
1.2. 地域別概要
1.3. セグメント別概要
1.3.1. 製品種類別
1.3.2. 用途別
1.3.3. エンドユース別
1.4. 主要トレンド
1.5. 不況の影響
1.6. アナリストの推奨および結論
第2章 世界の脱灰骨基質（DBM）市場の定義および調査の前提条件
2.1. 調査目的
2.2. 市場の定義
2.3. 調査の前提条件
2.3.1. 対象および除外
2.3.2. 制限
2.3.3. 供給サイド分析
2.3.3.1. 供給
2.3.3.2. インフラ
2.3.3.3. 規制環境
2.3.3.4. 市場競争
2.3.3.5. 経済的実現可能性（消費者視点
2.3.4. 需要側分析
2.3.4.1. 規制枠組み
2.3.4.2. 技術的進歩
2.3.4.3. 環境への配慮
2.3.4.4. 消費者意識と受容
2.4. 推定方法
2.5. 調査対象年
2.6. 通貨換算レート
第3章 世界の脱灰骨基質（DBM）市場のダイナミクス
3.1. 市場推進要因
3.1.1. 整形外科的疾患の増加
3.1.2. 組織工学の進歩
3.1.3. 交通事故および外傷の急増
3.2. 市場の課題
3.2.1. 代替品の入手可能性
3.2.2. 先進的なDBM製品のコスト高
3.3. 市場機会
3.3.1. アジア太平洋の新興市場
3.3.2. 再生医療における研究開発活動の活発化
第4章 グローバル脱灰骨基質（DBM）市場の業界分析
4.1. ポーターのファイブフォースモデル
4.2. PESTEL分析
4.3. トップ投資機会
4.4. 業界専門家による見解
4.5. アナリストによる推奨
第5章 グローバル脱灰骨基質（DBM）市場規模および製品種類別予測
5.1. セグメントダッシュボード
5.2. 製品種類別収益分析（2022年および2032年）
5.2.1. パテ
5.2.2. 繊維
5.2.3. スポンジ
5.2.4. ペースト
5.2.5. ゲル
5.2.6. その他
第6章 用途別脱灰骨基質（DBM）市場規模および予測
6.1. セグメントダッシュボード
6.2. 用途別収益分析（2022年および2032年）
6.2.1. 脊椎固定術
6.2.2. 関節再建術
6.2.3. 外傷治療
6.2.4. その他
第7章 世界の脱灰骨基質（DBM）市場規模および用途別予測
7.1. セグメントダッシュボード
7.2. エンドユース別収益分析（2022年および2032年
7.2.1. 外来患者施設
7.2.2. 病院
7.2.3. その他
第8章 世界の脱灰骨基質（DBM）市場規模および地域別予測
（RDに記載されているすべての地域および各国を含む）
第9章 競合情報
9.1. 主要企業のSWOT分析
9.1.1. Zimmer Biomet
9.1.2. Medtronic Plc
9.1.3. DePuy Synthes
9.2. トップ企業の市場戦略
9.3. 企業プロフィール
Zimmer Biomet
Medtronic Plc
DePuy Synthes
Stryker Corporation
Arthrex Inc
SeaSpine
Globus Medical
Berkeley Advanced Biomaterials
XTANT MEDICAL
LifeNet Health
Orthofix Medical
Integra LifeSciences
NuVasive Inc.
Aesculap Implant Systems
Bioventus
第10章 調査プロセス
10.1. データマイニング
10.2. 分析
10.3. 検証
DBM's rising adoption in orthopedic and regenerative medicine applications, coupled with advancements in tissue engineering technologies, has positioned it as a cornerstone in addressing the increasing prevalence of musculoskeletal disorders, trauma-related injuries, and bone-related diseases.
DBM stands out as a biomaterial for facilitating bone regeneration, particularly in spinal fusion, joint reconstruction, and trauma care procedures. With its osteoconductive and osteoinductive properties, DBM is increasingly preferred for both clinical and surgical applications. The expanding geriatric population, prone to degenerative bone conditions, and the growing trend toward minimally invasive surgical techniques are driving the global market growth.
The market dynamics are characterized by a surge in mergers and acquisitions, R&D investments, and technological innovations aimed at enhancing DBM's regenerative capabilities. For instance, the integration of bioactive agents and cleanroom processing techniques has significantly improved product efficacy, while minimizing sterility concerns. Additionally, DBM products continue to benefit from robust regulatory frameworks and FDA approvals, reinforcing their safety and reliability.
Regional analysis highlights North America's dominance, attributed to a higher prevalence of orthopedic conditions, a mature healthcare infrastructure, and strategic initiatives by market players. Meanwhile, Asia Pacific is emerging as the fastest-growing region, driven by its expanding aging population and advancements in healthcare accessibility.
Major market players included in this report are:
• Zimmer Biomet
• Medtronic Plc
• DePuy Synthes
• Stryker Corporation
• Arthrex Inc
• SeaSpine
• Globus Medical
• Berkeley Advanced Biomaterials
• XTANT MEDICAL
• LifeNet Health
• Orthofix Medical
• Integra LifeSciences
• NuVasive Inc.
• Aesculap Implant Systems
• Bioventus
The detailed segments and sub-segments of the market are as follows:
By Product Type
• Putty
• Fiber
• Sponge
• Paste
• Gel
• Others
By Application
• Spinal Fusion
• Joint Reconstruction
• Trauma Care
• Others
By End-Use
• Outpatient Facilities
• Hospitals
• Others
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Key Takeaways
• Market estimates and forecasts for 10 years from 2022 to 2032.
• Regional and country-level analysis of key growth trends.
• Comprehensive study of market drivers, challenges, and opportunities.
• Strategic insights into emerging trends and competitive landscape
Chapter 1. Global Demineralized Bone Matrix Market Executive Summary
1.1. Global Demineralized Bone Matrix Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Application
1.3.3. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Demineralized Bone Matrix Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Demineralized Bone Matrix Market Dynamics
3.1. Market Drivers
3.1.1. Increasing prevalence of orthopedic conditions
3.1.2. Advancements in tissue engineering
3.1.3. Surge in road accidents and trauma cases
3.2. Market Challenges
3.2.1. Availability of substitutes
3.2.2. High cost of advanced DBM products
3.3. Market Opportunities
3.3.1. Emerging markets in Asia Pacific
3.3.2. Rising R&D activities in regenerative medicine
Chapter 4. Global Demineralized Bone Matrix Market Industry Analysis
4.1. Porter’s Five Forces Model
4.2. PESTEL Analysis
4.3. Top Investment Opportunities
4.4. Industry Expert Perspectives
4.5. Analyst Recommendations
Chapter 5. Global Demineralized Bone Matrix Market Size & Forecasts by Product Type
5.1. Segment Dashboard
5.2. Revenue Analysis by Product Type (2022 & 2032)
5.2.1. Putty
5.2.2. Fiber
5.2.3. Sponge
5.2.4. Paste
5.2.5. Gel
5.2.6. Others
Chapter 6. Global Demineralized Bone Matrix Market Size & Forecasts by Application
6.1. Segment Dashboard
6.2. Revenue Analysis by Application (2022 & 2032)
6.2.1. Spinal Fusion
6.2.2. Joint Reconstruction
6.2.3. Trauma Care
6.2.4. Others
Chapter 7. Global Demineralized Bone Matrix Market Size & Forecasts by End-Use
7.1. Segment Dashboard
7.2. Revenue Analysis by End-Use (2022 & 2032)
7.2.1. Outpatient Facilities
7.2.2. Hospitals
7.2.3. Others
Chapter 8. Global Demineralized Bone Matrix Market Size & Forecasts by Region
(Include all regions and respective countries as mentioned in the RD.)
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Zimmer Biomet
9.1.2. Medtronic Plc
9.1.3. DePuy Synthes
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Zimmer Biomet
9.3.2. Medtronic Plc
9.3.3. DePuy Synthes
9.3.4. Stryker Corporation
9.3.5. Arthrex Inc
Chapter 10. Research Process
10.1. Data Mining
10.2. Analysis
10.3. Validation
❖ 掲載企業 ❖
Zimmer Biomet、Medtronic Plc、DePuy Synthes、Stryker Corporation、Arthrex Inc、SeaSpine、Globus Medical、Berkeley Advanced Biomaterials、XTANT MEDICAL、LifeNet Health、Orthofix Medical、Integra LifeSciences、NuVasive Inc.、Aesculap Implant Systems、Bioventusなど
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
